Reaction
Uterine Prolapse reporting signals
As of the last recalculation, Uterine Prolapse appears in 1,073 FAERS reports alongside 14 co-occurring drug terms. The strongest observed disproportionality signal is PRAMIPEXOLE (PRR 19.2).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Pramipexole | 15 | 19.2 | 19.3 |
| Lanreotide Acetate | 6 | 14.9 | 14.9 |
| Rasagiline Mesylate | 8 | 14.0 | 14.0 |
| Raloxifene Hydrochloride | 10 | 13.4 | 13.4 |
| Estrogens, Conjugated | 38 | 12.8 | 12.8 |
| Conjugated Estrogens | 37 | 12.7 | 12.7 |
| Fesoterodine Fumarate | 7 | 12.6 | 12.6 |
| Conjugated Estrogens And Medroxyprogesterone Acetate | 14 | 11.6 | 11.7 |
| Carbidopa And Levodopa | 24 | 10.0 | 10.0 |
| Diroximel Fumarate | 5 | 8.2 | 8.2 |
| Vibegron | 3 | 7.3 | 7.3 |
| Interferon Beta-1A | 65 | 6.9 | 6.9 |
| Copper | 8 | 3.6 | 3.6 |
| Levonorgestrel | 25 | 2.4 | 2.4 |